Genome Editing Market Highlights the Industry Attractiveness, Rising prevalence of the genetic diseases, Rise in the advancements of technologies, Rise in the production of genetically modified crops by 2027

The advantages of the CRISPR technology is found to be the revolutionary technique in the field of the biotechnology and it used for every procedure of the genome editing. The companies are engaged in the developing the techniques for its applications. For instance, Merck KGaA is multinational pharmaceutical, chemical and Life Sciences Company operating in business segments including healthcare, life science and performance material. In April, 2018, the company has received patent for CRISPR technology which used in genomic-integration method for eukaryotic cells. The patent was given by Chinese Patent Office. In addition, in February 2018, The Korean Intellectual Property Office and the Israel Patent Office granted individual patents to Merck for the company’s CRISPR technology used in a genomic-integration method for eukaryotic cells. Furthermore, in May, 2018, the company has collaborated with the Washington University in St. Louis, Missouri, USA, which led to the optimizing of nutritional supplements to restore a healthy gut microbial community (microbiome). The collaboration have utilized the CRISPR genome-editing technology for the research studies. Thus, the increase in the developments for the genome editing is likely to growth the market of genome editing in the coming forecast years.

According to a new market research study titled ‘Genome Editing Market to 2025 - Global Analysis and Forecasts by Technology, Application and End User, the global genome editing market was valued at US$ 3,210.1 Mn in 2017 and is estimated to reach US$ 10,691.0 Mn by 2025. The report highlights the trends prevalent in the global genome editing market and the factors driving the market along with the restraints that are impacting its growth

Genome Editing Market to 2025 - Global Analysis and Forecasts By Technology (TALENS, CRISPR, Zinc Finger Nucleases (ZFNs), and Others), Application (Genetic Engineering, Cell Line Engineering and Others), End User (Biotechnology & Pharmaceutical Companies, Contract Research Organizations (CROs), and Academic & Government Research Institutes) and Geography

Get Sample Copy at https://www.theinsightpartners.com/sample/TIPHE100000853

Global Genome Editing Market – By Technology

-TALENS
-CRISPR
-ZFN
-Others

Global Genome Editing Market – By Application

-Genetic Engineering
-Animal Genetic Engineering
-Plant Genetic Engineering
-Cell Line Engineering
-Others

Global Genome Editing Market – By End User

-Biotechnology & Pharmaceutical Companies
-Contract Research Organization (CROs)
-Academic & Government Research Institutes

Global Genome Editing Market – By Geography

-North America
-U.S.
-Canada
-Mexico

-Europe
-UK
-Germany
-France

-Asia Pacific (APAC)
-Japan
-China
-India

-Middle East & Africa (MEA)
-South Africa
-Saudi Arabia
-UAE

-South & Central America (SCAM)
-Brazil

Acquire Complete Report at https://www.theinsightpartners.com/buy/TIPHE100000853

About Us - The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services.

Contact us –

Contact Person : Sameer Joshi
Phone : +1-646-491-9876
Email Id : sam@theinsightpartners.com
Website: https://www.theinsightpartners.com

This release was published on openPR.